ScholarIQanswers from OpenAlex
Novo Nordisk
FunderResearch funding and supported work
Novo Nordisk is a funder indexed in ScholarIQ from OpenAlex.
What is known about Novo Nordisk?
ScholarIQrecord summary
Danish pharmaceutical company
How many works does Novo Nordisk have?
ScholarIQindexed works
Novo Nordisk has 46,090 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Novo Nordisk?
ScholarIQopenalex
The OpenAlex for Novo Nordisk is on the source record.
What is the ROR of Novo Nordisk?
ScholarIQror
The ROR for Novo Nordisk is on the source record.
What are the most-cited papers on Novo Nordisk?
ScholarIQmost cited works
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William C. Duckworth, Carlos Abraira, Thomas Moritz, Domenic J. Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer A. Marks, Stephen N. Davis, Rodney A. Hayward, Stuart Warren, Steven Goldman, Madeline McCarren, Mary Ellen Vitek, William G. Henderson, Grant D. Huang
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, Kenneth W. Mahaffey, Johannes F.E. Mann, George L. Bakris, Florian M.M. Baeres, Thomas Idorn, Heidrun Bosch‐Traberg, Nanna L. Lausvig, Richard Pratley
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
Domenica Rubino, Domenica Rubino, Niclas Abrahamsson, Melanie Davies, Dan Hesse, Frank L. Greenway, Camilla Jensen, Ildiko Lingvay, Ofri Mosenzon, Julio Rosenstock, Miguel A. Rubio, Gottfried Rudofsky, Sayeh Tadayon, Thomas A. Wadden, Dror Dicker, STEP 4 Investigators, M. Friberg, Anders Sjödin, Dror Dicker, Gabriella Segal, Ofri Mosenzon, Muhammad Sabbah, Yael Sofer, Victor Vishlitzky, Eelco W. Meesters, Mirelle Serlie, Arianne van Bon, Helena Cardoso, Paula Freitas, Pedro Carneiro de Melo, Mariana P. Monteiro, Mariana Monteiro, Dírcea Rodrigues, Aysha Badat, P Joshi, Gulam Latiff, Essack A. Mitha, Hans H. Snyman, Elane van Nieuwenhuizen, Olga González Albarrán, Assumpta Caixàs, Carmen de al Cuesta, Pedro Pablo Garcia Luna, Cristobal Morales Portillo, Pedro Mezquita Raya, Miguel Angel Rubio, Niclas Abrahamsson, Johan Hoffstedt, Fredrik von Wowern, Erik Uddman, Birgit Bach-Kliegel, Felix Beuschlein, Stefan Bilz, Alain Golay, Gottfried Rudofsky, Christopher Strey, Н. В. Косей, Т. Ф Татарчук, Тетяна Татарчук, Valentyna Velychko, Olesya Zinych, Stephen Aronoff, Harold E. Bays, Andrew P. Brockmyre, Robert S. Call, Charles Crump, Cyrus V. Desouza, Valerie Espinosa, Almena Free, Winston H. Gandy, Steven A. Geller, Gregory Gottschlich, Frank L. Greenway, Laurie Han-Conrad, Wayne Harper, L A Herman, Mitzie Hewitt, Ph. Hollander, Steven R. Kaster, Anastasios Manessis, Frederick A. Martin, Robert E. McNeill, Alexander V. Murray, Paul Norwood, John C.H. Reed, Julio Rosenstock, Domenica M. Rubino, Domenica M. Rubino, Martin Schear, Mark Warren